News Daily News Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis Todd Neale November 28, 2024
News Conference News AHA 2024 Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients Shelley Wood November 16, 2024
News Daily News Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge L.A. McKeown October 15, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Daily News New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients L.A. McKeown August 19, 2024
News Conference News ESOC 2024 INTERACT4: Impact of Prehospital BP-Lowering May Depend on Acute Stroke Type Todd Neale May 20, 2024
News Conference News ESOC 2024 Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60 Todd Neale May 17, 2024
News Conference News ESOC 2024 Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet Todd Neale May 16, 2024
News Conference News EHRA 2024 Stroke Rates Fall Among AF Patients Not on Anticoagulation Todd Neale April 11, 2024
News Daily News LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play Todd Neale March 15, 2024
News Daily News Salt Substitute Slashes New Hypertension Diagnoses: DECIDE-Salt L.A. McKeown February 14, 2024